Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil. A total of 30 pediatric patients suffering from lower-respiratory-tract infections were admitted to a three-arm, open, randomized study comparing two different doses of cefetamet pivoxil (either 10 or 20 mg/kg b.i.d. groups A and B, respectively) with the standard cefaclor treatment (10 mg/kg t.i.d.